Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4856-4859

  Knight, Sean ^a   Bokhoven, Marieke ^a   Collins, Mary ^a   Takeuchi, Yasuhiro ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; GENE ACTIVATION; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MUTAGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANS SPLICING; TRANSCRIPTION INITIATION;

CELL LINE; GENE EXPRESSION PROFILING; GENE THERAPY; GENETIC VECTORS; HIV LONG TERMINAL REPEAT; HUMANS; LENTIVIRUS; MUTAGENESIS, INSERTIONAL; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 77950841386     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02476-09     Document Type: Article

References (15)

1. Akagi, K., T. Suzuki, R. M. Stephens, N. A. Jenkins, and N. G. Copeland. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32:D523-D527. (Pubitemid 38081713)
2. Arumugam, P. I., T. Higashimoto, F. Urbinati, U. Modlich, S. Nestheide, P. Xia, C. Fox, A. Corsinotti, C. Baum, and P. Malik. 2009. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol. Ther. 17:1929-1937.
3. Bokhoven, M., S. L. Stephen, S. Knight, E. F. Gevers, I. C. Robinson, Y. Takeuchi, and M. K. Collins. 2009. Insertional gene activation by lentiviral and gammaretroviral vectors. J. Virol. 83:283-294.
4. Collins, M. K., J. Marvel, P. Malde, and A. Lopez-Rivas. 1992. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med. 176:1043-1051.
5. Demaison, C., K. Parsley, G. Brouns, M. Scherr, K. Battmer, C. Kinnon, M. Grez, and A. J. Thrasher. 2002. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13:803-813.
6. Hacein-Bey-Abina, S., A. Garrigue, G. P. Wang, J. Soulier, A. Lim, E. Morillon, E. Clappier, L. Caccavelli, E. Delabesse, K. Beldjord, V. Asnafi, E. MacIntyre, L. Dal Cortivo, I. Radford, N. Brousse, F. Sigaux, D. Moshous, J. Hauer, A. Borkhardt, B. H. Belohradsky, U. Wintergerst, M. C. Velez, L. Leiva, R. Sorensen, N. Wulffraat, S. Blanche, F. D. Bushman, A. Fischer, and M. Cavazzana-Calvo. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118:3132-3142.
7. Howe, S. J., M. R. Mansour, K. Schwarzwaelder, C. Bartholomae, M. Hubank, H. Kempski, M. H. Brugman, K. Pike-Overzet, S. J. Chatters, D. de Ridder, K. C. Gilmour, S. Adams, S. I. Thornhill, K. L. Parsley, F. J. Staal, R. E. Gale, D. C. Linch, J. Bayford, L. Brown, M. Quaye, C. Kinnon, P. Ancliff, D. K. Webb, M. Schmidt, C. von Kalle, H. B. Gaspar, and A. J. Thrasher. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118:3143-3150.
8. Humeau, L. M., G. K. Binder, X. Lu, V. Slepushkin, R. Merling, P. Echeagaray, M. Pereira, T. Slepushkina, S. Barnett, L. K. Dropulic, R. Carroll, B. L. Levine, C. H. June, and B. Dropulic. 2004. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol. Ther. 9:902-913.
9. Levine, B. L., L. M. Humeau, J. Boyer, R. R. MacGregor, T. Rebello, X. Lu, G. K. Binder, V. Slepushkin, F. Lemiale, J. R. Mascola, F. D. Bushman, B. Dropulic, and C. H. June. 2006. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 103:17372-17377.
10. Maruggi, G., S. Porcellini, G. Facchini, S. K. Perna, C. Cattoglio, D. Sartori, A. Ambrosi, A. Schambach, C. Baum, C. Bonini, C. Bovolenta, F. Mavilio, and A. Recchia. 2009. Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design. Mol. Ther. 17:851-856.
11. Modlich, U., J. Bohne, M. Schmidt, C. von Kalle, S. Knoss, A. Schambach, and C. Baum. 2006. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 108:2545-2553.
12. Modlich, U., S. Navarro, D. Zychlinski, T. Maetzig, S. Knoess, M. H. Brugman, A. Schambach, S. Charrier, A. Galy, A. J. Thrasher, J. Bueren, and C. Baum. 2009. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol. Ther. 17:1919-1928.
13. Montini, E., D. Cesana, M. Schmidt, F. Sanvito, C. C. Bartholomae, M. Ranzani, F. Benedicenti, L. S. Sergi, A. Ambrosi, M. Ponzoni, C. Doglioni, C. Di Serio, C. von Kalle, and L. Naldini. 2009. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J. Clin. Invest. 119:964-975.
14. Montini, E., D. Cesana, M. Schmidt, F. Sanvito, M. Ponzoni, C. Bartholomae, L. Sergi Sergi, F. Benedicenti, A. Ambrosi, C. Di Serio, C. Doglioni, C. von Kalle, and L. Naldini. 2006. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 24:687-696.
15. Uren, A. G., J. Kool, A. Berns, and M. van Lohuizen. 2005. Retroviral insertional mutagenesis: past, present and future. Oncogene 24:7656-7672. (Pubitemid 41670669)